http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9650614-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e1a13fa20654594de6c181702ab3087d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b77b8ae94a756fd8cbdc6461090bf513
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y207-10001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-53
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0011
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
filingDate 2015-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddd303b54ffc97dca321e2da6474985c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9bd3e346f53f8b2ce12c215bf86c48b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_57ee6b6533e04adf30b911efc4fdd40e
publicationDate 2017-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-9650614-B2
titleOfInvention Anaplastic lymphoma kinase (ALK) as oncoantigen for lymphoma vaccination
abstract Use of intracytoplasmatic domain of Anaplastic Lymphoma Kinase (ALK) protein and/or a nucleic acid molecule encoding for the intracytoplasmatic domain of Anaplastic Lymphoma Kinase (ALK) protein, of any species, for the preparation of a medicament, preferably a vaccine, for the treatment and/or prevention of a tumor in a subject, preferably a lymphoma.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11623002-B2
priorityDate 2007-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03042243-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5978
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395467
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19366879
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395468
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399167
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4112
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394204
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396360
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11245343
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226590673
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394386
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID249332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395834
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6331297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19960016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394205
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5755
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11048
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID229800850
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID577022
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226439180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID320930
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395833

Total number of triples: 61.